Advertisement: The ONE Group
RealVNC mid banner careers
10 April, 2019 - 11:59 By Kate Sweeney

Southan promoted to CEO at Metrion Biosciences

Andy Southan Metrion

Metrion Biosciences, an ion channel contract research and drug discovery company based in Cambridge, has promoted chief operating officer Dr Andrew Southan to CEO.

He has over 25 years of experience in ion channel research and development, starting his career at Wyeth Research (UK), followed by postdoctoral studies at Imperial College London.

He has also held leadership roles at CeNeS Pharmaceuticals and Ionix Pharmaceuticals and spent 12 years leading and expanding the UK ion channel team for BioFocus and Charles River Laboratories.

Newsletter Subscription

Stay informed of the latest news and features